Evidence map›Paper›PMID 42345642›Full record

ReviewAdvances in respiratory medicine2026

Characteristics of Respiratory Microbiome in COPD-A Literature Review.

Iga Ciesielska-Markowska, Katarzyna Mycroft-Rzeszotarska, Piotr Korczyński, Kaja Pulik, Katarzyna Górska

Abstract readReview
In one paragraph

Review in Advances in respiratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Iga Ciesielska-MarkowskaDepartment of Internal Medicine, Pulmonary Diseases & Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland.
Katarzyna Mycroft-RzeszotarskaDepartment of Internal Medicine, Pulmonary Diseases & Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland.
Piotr KorczyńskiDepartment of Pulmonology, Internal Medicine, Thoracic Oncology and Transplantology, National Medical Institute of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.ORCID 0000-0003-2826-4430
Kaja PulikDepartment of Internal Medicine, Pulmonary Diseases & Allergy, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0003-3724-1804
Katarzyna GórskaDepartment of Pulmonology, Internal Medicine, Thoracic Oncology and Transplantology, National Medical Institute of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.ORCID 0000-0003-4686-910X

Funding

National Science Centre 2019/35/B/NZ5/00694
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a respiratory disease that progressively impairs airway function. Its aetiology and clinical presentation are very complex, resulting in an unpredictable course of the disease. The most important causes include smoking and environmental pollutants. However, upper airway microbiome dysbiosis has been linked with COPD severity. Through this review, we aim to compare the microbiome of the respiratory tract between its sites, and to see if there are any significant differences in the composition of the microbial flora of patients with COPD when compared to healthy individuals. While preparing this review, the PubMed database was searched using keywords such as bacteriome, COPD, exacerbation, and microbiome. Analysis of the airway microbiome shows that the three most abundant phyla are Firmicutes, Proteobacteria, and Bacteroidetes. The severity of the disease and the selected therapeutic methods influence the ratio of Proteobacteria and Firmicutes. It has been observed that a decrease in microbial diversity resulted in lower values of FEV1 in patients and could be related with COPD's progress and exacerbation events. While exacerbation cases need quick treatment, COPD's complex background makes it difficult to find a singular, microbial cause.

Indexed as

MicrobiotaPulmonary Disease, Chronic ObstructiveRespiratory SystemHumansbacteriomeCOPDexacerbationmicrobiomesmokingsputum inductionstabletreatment

Identifiers

PMID42345642
PMCPMC13296001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.